Proportion of BPH patients with symptom improvement of at least 3 points on IPSS: Doxazosin vs alfuzosin

被引：0
|
作者：
Dereijke, TM
机构：
来源：
JOURNAL OF UROLOGY | 2002年 / 167卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：376 / 376
页数：1
相关论文
共 35 条
  • [21] Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD - A Detailed Analysis
    Watz, Henrik
    Rickard, Kathleen
    Rheault, Tara
    Bengtsson, Thomas
    Singh, Dave
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 2199 - 2206
  • [22] PATIENT-REPORTED SYMPTOM IMPROVEMENT IN SLEEP MAINTENANCE ENDPOINTS IN ADULT AND ELDERLY PATIENTS WITH INSOMNIA TREATED WITH DOXEPIN 3 AND 6 MG
    Lankford, A.
    Krystal, A. D.
    Dorsey, B.
    Rogowski, R.
    Ludington, E.
    Durrence, H.
    Davis, C. S.
    Roth, T.
    SLEEP, 2011, 34 : A175 - A175
  • [23] Bronchodilation and Symptom Improvement with Ensifentrine, A Dual PDE3/4 Inhibitor: Sub-Group Analyses of a Four Week Randomized, Controlled Trial in Patients with COPD
    Rheault, T.
    Rickard, K.
    Bengtsson, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [24] Risankizumab Versus Ustekinumab for the Achievement of Clinical Outcomes and Symptom Improvement in Patients With Moderate To Severe Crohn's Disease: Results From the Phase 3b SEQUENCE Trial
    Dubinsky, M. C.
    D'Haens, G.
    Atreya, R.
    Abraham, B.
    Armuzzi, A.
    Arguelles-Arias, F.
    Lindsay, J. O.
    Patel, K.
    Neimark, E.
    Huang, X.
    Anschutz, T.
    van Haaren, S.
    O'Brien, D.
    Ferrante, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I65 - I66
  • [25] Obese patients with CEAP (clinical, etiology, anatomy, pathophysiology) C2 and C3 disease show enhanced symptom improvement after endovenous thermal ablation
    Zottola, Zachary R.
    Geiger, Joshua T.
    Choo, Geena E.
    Kedwai, Baqir J.
    Balceniuk, Mark D.
    Ellis, Jennifer L.
    Doyle, Adam J.
    Newhall, Karina A.
    JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2024, 12 (04)
  • [26] Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naive First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy
    Wang, Keqiang
    Xiu, Meihong
    Su, Xiuru
    Wu, Fengchun
    Zhang, Xiangyang
    ANTIOXIDANTS, 2022, 11 (04)
  • [27] Naloxegol Provides Clinically Meaningful Symptom Improvement (PAC-SYM) in Patients With Opioid-Induced Constipation (OIC): A Pooled Analysis of Two Global Phase 3 Studies of Naloxegol
    Brenner, Darren M.
    Rockett, Carol
    Jamindar, Mansi
    Bortey, Enoch
    Almenoff, June
    Cash, Brooks D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S129 - S130
  • [28] A NOVEL SCORE TO EVALUATE ABDOMINAL SYMPTOM IMPROVEMENT IN PATIENTS WITH CONSTIPATION-PREDOMINANT IBS DEMONSTRATES EFFICACY OF LINACLOTIDE FOR IMPROVING ABDOMINAL BLOATING, DISCOMFORT, AND PAIN IN A PHASE 3B TRIAL
    Chang, Lin
    Lacy, Brian E.
    Moshiree, Baha
    Kassebaum, Amy
    Abel, Jessica L.
    Hanlon, Jennifer
    Bartolini, Wilmin
    Boinpally, Ramesh
    Bochenek, Wieslaw
    Fox, Susan M.
    Mallick, Madhuja
    Tripp, Ken
    Omniewski, Nicholas
    Shea, Elizabeth P.
    Borgstein, Niels
    GASTROENTEROLOGY, 2020, 158 (06) : S891 - S891
  • [29] Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance])
    Sio, Terence T.
    Atherton, Pamela J.
    Birckhead, Brandon J.
    Schwartz, David J.
    Sloan, Jeff A.
    Seisler, Drew K.
    Martenson, James A.
    Loprinzi, Charles L.
    Griffin, Patricia C.
    Morton, Roscoe F.
    Anders, Jon C.
    Stoffel, Thomas J.
    Haselow, Robert E.
    Mowat, Rex B.
    Wittich, Michelle A. Neben
    Bearden, James D., III
    Miller, Robert C.
    SUPPORTIVE CARE IN CANCER, 2016, 24 (09) : 3847 - 3855
  • [30] Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance])
    Terence T. Sio
    Pamela J. Atherton
    Brandon J. Birckhead
    David J. Schwartz
    Jeff A. Sloan
    Drew K. Seisler
    James A. Martenson
    Charles L. Loprinzi
    Patricia C. Griffin
    Roscoe F. Morton
    Jon C. Anders
    Thomas J. Stoffel
    Robert E. Haselow
    Rex B. Mowat
    Michelle A. Neben Wittich
    James D. Bearden
    Robert C. Miller
    Supportive Care in Cancer, 2016, 24 : 3847 - 3855
1234